Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: The role of leukotriene B4

European Respiratory Journal

Volumn 15, Issue 2, 2000, Pages 274-280

  Crooks, S W ^a   Bayley, D L ^a   Hill, S L ^a   Stockley, R A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Chronic bronchitis; Exacerbation; Inflammation; Leukotriene B4; Neutrophil

Indexed keywords

INTERLEUKIN 8; LEUKOTRIENE B4; MYELOPEROXIDASE;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; INFLAMMATORY DISEASE; LUNG FUNCTION TEST; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SPUTUM EXAMINATION;

ACUTE-PHASE PROTEINS; AGED; BACTERIAL INFECTIONS; BRONCHITIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKOTRIENE B4; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; NEUTROPHILS; SPUTUM;

EID: 0033951642     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15b09.x     Document Type: Article

References (30)

1. Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis: characterisation and correlation with clinical parameters. Am Rev Respir Dis 1989; 140: 1527-1537.
2. Saetta M, Turato G, Facchini FM, et al. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 1633-1639.
3. Stockley RA. The pathogenesis of chronic obstructive lung diseases: implications for therapy. QJM 1995; 88: 141-146.
4. Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory diseases. Am J Physiol 1993; 264: L413-L418.
5. Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol 1998; 30: 173-178.
6. Stockley RA. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection. Thorax 1998; 53: 58-62.
7. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 142: 1067-1063.
8. Anthonisen NR, Manfreda J, Waren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
9. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisolone in out-patients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154: 407-412.
10. Nocker RE, Schoonbrood DF, van de Graaf EA, et al. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 1996; 109: 183-191.
11. O'Driscoll BRC, Cromwell O, Kay AB. Sputum leukotrienes in obstructive airway diseases. Clin Exp Immunol 1984; 55: 397-404.
12. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1965; i: 775-779.
13. Llewellyn-Jones CG, Harris TAJ, Stockley RA. The effect of fluticasone propionate on sputum of patients of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153: 616-621.
14. Morrison HM, Kramps JA, Afford CS, Burnett D, Stockley RA. The effect of assay condition on the measurement of anti-elastase function in lung secretions. Clin Chim Acta 1987; 162: 165-17.
15. Falk W, Goodwin RH Jr., Leonard EJ. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 1980; 33: 239-247.
16. Marder P, Sawyer JS, Froelich LL, Mann LL, Spaethe SM. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5hydroxyphenoxy]propoxy]phenoxy] benzoic acid (LY293111 ), a novel leukotriene B4 receptor antagonist. Biochem Pharmacol 1995; 49: 1683-1690.
17. Mikami M, Llewellyn-Jones CG, Bayley D, Hill SL, Stockley RA. The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med 1998; 157: 723-728.
18. Anonymous. Guidelines for the measurement of respiratory function. Respir Med 1994; 88: 165-194.
19. Anonymous. Antibiotics for exacerbations of chronic bronchitis. Lancet 1987; ii: 23.
20. Riise GC, Ahlstedt S, Larsson S, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50: 360-365.
21. Stockley RA, Burnett D. Alpha-1-antitrypsin and leukocyte elastase in infected and noninfected sputum. Am Rev Respir Dis 1979; 120: 1081-1086.
22. Amitani R, Wilson R, Rutman R, et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol 1991; 4: 26-32.
23. Stockley RA. Bronchiectasis - new therapeutic approaches based on pathogenesis. Clin Chest Med 1987; 8: 481-494.
24. Kanner RE, Renzetti AD Jr., Klauber MR, Smith CB, Golden CA. Variables associated with changes in spirometry in patients with obstructive lung diseases. Am J Med 1979; 67: 44-50.
25. Bates DV. The fate of the chronic bronchitic: a report of the ten year follow up in the Canadian Department of Veteran's Affairs coordinated study in chronic bronchitis. Am Rev Respir Dis 1973; 108: 1043-1065.
26. Fels AOS, Pawlowski NA, Cramer EB, King TCK, Cohn ZA, Scott WA. Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci USA 1982; 79: 7866-7870.
27. Bigby TD, Lee DM, Meslier N, Gruenert DC. Leukotriene A4 hydrolase activity of human airway epithelial cells. Biochem Biophys Res Commun 1989; 164: 1-7.
28. Borgeat P, Krump E, Palmantier R, et al. The synthesis of leukotrienes by the human neutrophil. In: Holgate S, Dahlen S-E, eds. SRS-A to Leukotrienes. Oxford, Blackwell. 1997; pp. 69-84.
29. Martin TR, Pistorese BP, Chi KY, Goodman RB, Mathay MA. Effect of leukotriene B4 on the human lung. Recruitment of proteins into the alveolar spaces without a change in protein permeability. J Clin Invest 1989; 84: 1609-1619.
30. Barnes PJ. New therapies for chronic obstructive pulmonary disease. Thorax 1998; 53: 137-147.